Health Tech Capitol | Erik Greenfield
7
archive,paged,author,author-egreenfield,author-7,paged-18,author-paged-18,tribe-no-js,tribe-bar-is-disabled,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-9.3,wpb-js-composer js-comp-ver-4.12,vc_responsive

Author: Erik Greenfield

MADISON, Wis. and SAN DIEGO, Oct. 18, 2018 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS) today announced the acquisition of Biomatrica, a leading developer, manufacturer and provider of sample preservation technology, including blood and saliva sample collection tubes, to the biotech industry. Biomatrica's sample collection...

New research from Propeller Health, a leading digital therapeutics company, suggests that clinical guidelines for assessing asthma control may need to be updated to reflect objective patient information obtained from digital medicines. The analysis, done in partnership with the University of Colorado School of Medicine and Children's Hospital...

Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today updates interim overall survival (OS) data from the company’s ongoing Phase 1b clinical trial evaluating CLR 131 for the treatment of relapsed/refractory...

MADISON, Wis.--Redox today announced that it has launched “Redox Gives,” a charitable program aimed at serving healthcare non-profits and public health organizations that help at-risk portions of the population gain access to quality health services at little or no cost. Qualifying non-profit organizations or social enterprises...